Gerald Erskine, DPM
Primary Podiatric Medicine · Ronceverte, WVNPI 1346350030
Payments from drug & device makers
Across 53 payments — averaging $112.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$5K
- Convatec Inc.$140
- Averitas Pharma Inc.$82
- Heron Therapeutics, Inc.$80
- Stryker$69
- Kerecis Limited$55
- plus $164 from 5 others
What the payments were for
- Travel & lodging$3,85065%
- Food & beverage$2,08735%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 37 | $5,364 |
| Convatec Inc. | 2 | $140 |
| Averitas Pharma Inc. | 2 | $82 |
| Heron Therapeutics, Inc. | 1 | $80 |
| Stryker | 1 | $69 |
| Kerecis Limited | 1 | $55 |
| Organogenesis Inc. | 3 | $48 |
| Smith+Nephew | 2 | $40 |
| Amgen | 2 | $30 |
| Bioventus LLC | 1 | $29 |
| Nevro Corp. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,904
- Lapiplasty$680
- TMC NANOPLASTY SYSTEM$632
- InnovaMatrix AC$125
How this compares
Too few primary podiatric medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 12 | $8,098 |
| Vancomycin Hcl | 11 | $2,292 |
| Ketoconazole | 11 | $803 |
| Ammonium Lactate | 16 | $484 |
| Mupirocin | 29 | $257 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $219 |
| Clindamycin Hcl | 17 | $157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $105 |
| Triamcinolone Acetonide | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Ronceverte
- Martin MrozekFayetteville$671
- John WhiteHurricane$480
- Matthew PolkBerkeley Springs$206
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.